Detalhe da pesquisa
1.
A trimeric structural fusion of an antagonistic tumor necrosis factor-α mutant enhances molecular stability and enables facile modification.
J Biol Chem
; 292(16): 6438-6451, 2017 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28235800
2.
Consecutive incorporation of functionalized nucleotides with amphiphilic side chains by novel KOD polymerase mutant.
Bioorg Med Chem Lett
; 26(2): 530-533, 2016 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26627581
3.
Lysine-deficient lymphotoxin-α mutant for site-specific PEGylation.
Cytokine
; 56(2): 489-93, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21871814
4.
Creation of a lysine-deficient LIGHT mutant with the capacity for site-specific PEGylation and low affinity for a decoy receptor.
Biochem Biophys Res Commun
; 393(4): 888-93, 2010 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-20175993
5.
Design of a pH-sensitive polymeric carrier for drug release and its application in cancer therapy.
Clin Cancer Res
; 10(7): 2545-50, 2004 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15073135
6.
The use of PVP as a polymeric carrier to improve the plasma half-life of drugs.
Biomaterials
; 25(16): 3259-66, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-14980420
7.
The targeting of anionized polyvinylpyrrolidone to the renal system.
Biomaterials
; 25(18): 4309-15, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15046921
8.
Effective accumulation of poly(vinylpyrrolidone-co-vinyl laurate) into the spleen.
J Biomed Mater Res A
; 70(2): 219-23, 2004 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15227666
9.
Effect of amorphous silica nanoparticles on in vitro RANKL-induced osteoclast differentiation in murine macrophages.
Nanoscale Res Lett
; 6(1): 464, 2011 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-21777482
10.
Therapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis mice.
J Control Release
; 149(1): 8-14, 2011 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20036293
11.
The augmentation of intracellular delivery of peptide therapeutics by artificial protein transduction domains.
Biomaterials
; 30(19): 3318-23, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19304319
12.
Promotion of optimized protein therapy by bioconjugation as a polymeric DDS.
Anticancer Agents Med Chem
; 6(3): 251-8, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16712453
13.
Selective enhancer of tumor vascular permeability for optimization of cancer chemotherapy.
Biol Pharm Bull
; 27(3): 437-9, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-14993819